Exor Capital LLP Lantheus Holdings, Inc. Transaction History
Exor Capital LLP
- $4.06 Billion
- Q3 2025
Shares
2 transactions
Others Institutions Holding LNTH
# of Institutions
478Shares Held
68.9MCall Options Held
522KPut Options Held
312K-
Black Rock Inc. New York, NY8.6MShares$456 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.95MShares$369 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X06.68MShares$354 Million0.17% of portfolio
-
Morgan Stanley New York, NY3.88MShares$206 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA3.48MShares$184 Million0.77% of portfolio
About Lantheus Holdings, Inc.
- Ticker LNTH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 68,741,904
- Market Cap $3.64B
- Description
- Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...